14 Respiratory disease
Questions
As a third-year medical student in Russia I am researching ‘the role of proteolytic enzymes and their inhibitors in lung pathology’. Can you explain how proteolytic enzymes function in the normal lung?
In bronchiectasis, what is the reason for using a bronchodilator if the airways are already dilated?
Please could you tell me the skin-prick test result for non-infected and non-immune tuberculosis carriers?
I am a final-year medical student in India, where tuberculosis in all forms is one of the most common diseases with which we deal. I read that you feel there is no indication for steroids in tuberculosis. Is it not reasonable to give steroids with antitubercular therapy (ATT) in a patient with tuberculous pericarditis, meningitis, peritonitis and ocular manifestations due to tuberculosis, in order to reduce the damage caused by inflammation and fibrosis? If not, what suitable alternatives, other than steroids, would you recommend to reduce damage from postinflammatory fibrosis?
We have read in your book that continuous oxygen therapy at home reduces mortality in chronic obstructive pulmonary disease (COPD). I am concerned that my patient might develop acute respiratory failure.
Why is serum angiotensin-converting enzyme (ACE) high in sarcoidosis? And is there a difference between pulmonary and extrapulmonary sarcoidosis regarding the high serum ACE level in that disease?
Alpha1-antitrypsin inhibits neutrophil elastase, a proteolytic enzyme capable of destroying alveolar wall connective tissue. Alpha1-antitrypsin deficiency allows damage to occur to distal lung tissue with the development of emphysema. Neutrophil elastase is the most abundant antiprotease in the lung and as smoking stimulates elastase release, lung tissue damage occurs leading to worsening emphysema.
Acute bronchitis is literally inflammation of the bronchi; it is usually viral in origin. Pneumonia is inflammation of the lung substance and is most commonly due to bacteria; over 50% being due to Streptococcus pneumoniae.
No regimen of steroid usage is the best. Alternate-day administration has not been successful in asthma because patients can deteriorate during the second 24 hours. There is certainly no need to give therapeutic steroids more than once daily except when initiating steroids for acute severe asthma. As with all drugs, it is best to get to know how to use the drug by seeing many patients. The stepwise management of asthma is shown in Table 14.1.
Step | Peak expiratory flow rate | Treatment |
---|---|---|
1. Occasional symptoms, less frequent than once a day | 100% predicted | As-required bronchodilators If used more than once daily, move to step 2 |
2. Daily symptoms | ≤ 80% predicted | Anti-inflammatory drugs: Sodium cromoglicate or lowdose inhaled corticosteroids up to 800 μg If not controlled, move to step 3 |
3. Severe symptoms | 50-80% predicted | High-dose inhaled corticosteroids up to 2000 μg daily |
4. Severe symptoms uncontrolled with high-dose inhaled corticosteroids | 50-80% predicted | Add regular long-acting beta2 agonist (e.g. salmeterol) |
5. Severe symptoms deteriorating | ≤ 50% predicted | Add prednisolone 40 mg daily |
6. Severe symptoms deteriorating in spite of prednisolone | ≤ 30% predicted | Hospital admission |
Short-acting bronchodilator treatment can be taken at any step on an as-required basis.
There are a number of different ways of classifying pneumonia. These include:
The classical description of typical pneumonia due to pneumococcus is:
The details of these are available in many books of pathology.
Following intradermal tuberculin challenge in a sensitized individual, antigen-specific memory T cells are activated to secrete interferon gamma (IFN-γ), which activates macrophages to produce more cytokines. BCG induces cellular immunity to the TB bacillus, which is an intracellular organism, in an unsensitized individual (Box 14.1).
The use of steroids is still controversial. In TB pericarditis, the European Society of Cardiology gives it a class II b recommendation (usefulness of efficacy less well established by evidence). The American Thoracic Society recommends steroids in the first 11 weeks. There is a growing base of clinical data for the use of steroids in meningitis; in one study it improved mortality.
Crocidolite fibres are long and thin and easily impact in the small airways where they are engulfed by macrophages. How exactly they get into the pleura is unclear, but they do because they can be found in pathological specimens.
No! Fatalities have occurred in this situation. It would be reasonable to add a long-acting beta2-agonist so that the inhaled steroids can be reduced. Patients should be warned about the possible exacerbation of their asthma that can occur with the addition of long-term beta2-agonists.
Hiccough lasting greater than 48 hours certainly occurs with brainstem lesions with raised intracranial pressure. It is not, however, an early sign of raised pressure.